curATime – Cluster for Atherothrombosis and Individualized Medicine among the finalists of the BMBF’s “Clusters4Future” initiative

We are very proud to have been selected for the concept phase of the “Clusters4Future” initiative of the Federal Ministry of Education and Research (BMBF). Among this year’s 15 finalists is the cluster concept “curATime – Cluster for Atherothrombosis and Individualized Medicine”, which was developed in collaboration between TRON gGmbH, the Center for Thrombosis and Hemostasis (CTH) at Mainz University Medical Center and the German Research Center for Artificial Intelligence (DFKI). In curATime, artificial intelligence-driven biomarker research will be combined with immunological solution approaches to develop individually targeted treatment and prevention concepts for cardiovascular diseases and to transfer them into clinical application.

For more information, please see the official press release.